Family Medicine · El Paso, TX
NPI
1528028099
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
10500 Vista del Sol Dr Ste C
El Paso, TX, 79925
Phone (915) 444-8571
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
3,083 services
Medicare patients, 2024
203
Average age 74
Drug cost, 2024
$2.1M
23,570 prescriptions
Company payments, 2025
$1,610
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alejandro Rocha Jr. was code J1010 (injection, methylprednisolone acetate, 1 mg), 816 times for 12 patients. In total Alejandro Rocha Jr. billed 3,083 services in 56 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 816 | 12 | $0.09 | $72.95 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 634 | 81 | $42.18 | $27K |
| 99214 Office E&M - Established | Office | 481 | 167 | $80.85 | $39K |
| 99213 Office E&M - Established | Office | 225 | 97 | $59.58 | $13K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 218 | 24 | $0.08 | $17.28 |
| 96372 Injection Administration | Office | 164 | 70 | $9.45 | $1,550 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 120 | 24 | $0.30 | $36.57 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 73 | 33 | $0.85 | $62.36 |
| 81003 Clinical Chemistry | Office | 36 | 31 | $2.20 | $79.2 |
| 11721 Nail Procedure | Office | 30 | 14 | $28.16 | $845 |
| G0008 Administration of influenza virus vaccine | Office | 21 | 21 | $31.03 | $652 |
| 90656 Vaccine Product | Office | 21 | 21 | $21.90 | $460 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 19 | 13 | $34.71 | $659 |
| 99204 Office E&M - New | Office | 19 | 19 | $93.48 | $1,776 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 17 | 17 | $123.81 | $2,105 |
By year: 2022 $104K for 2,675 services; 2023 $120K for 3,465 services; 2024 $93K for 3,083 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 36 | 31 | $2.20 | $79.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Alejandro Rocha Jr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,108 prescriptions and refills. In total Alejandro Rocha Jr. wrote 23,570 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,108 | 3,204 | 380 | $8,907 |
| Metformin Hcl Generic | 1,090 | 3,098 | 363 | $6,490 |
| Lisinopril Generic | 927 | 2,625 | 288 | $7,106 |
| Levothyroxine Sodium Generic | 822 | 2,321 | 260 | $6,819 |
| Amlodipine Besylate Generic | 797 | 2,232 | 265 | $3,887 |
| Zolpidem Tartrate Generic | 701 | 708 | 113 | $4,800 |
| Losartan Potassium Generic | 549 | 1,595 | 177 | $4,537 |
| Gabapentin Generic | 542 | 981 | 194 | $8,148 |
| Tramadol Hcl Generic | 508 | 508 | 123 | $3,096 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 489 | 1,350 | 210 | $7,142 |
| Rosuvastatin Calcium Generic | 465 | 1,395 | 165 | $4,362 |
| Alprazolam Generic | 442 | 442 | 89 | $1,106 |
| Omeprazole Generic | 426 | 1,183 | 159 | $8,326 |
| Ibuprofen Generic | 421 | 572 | 174 | $3,332 |
| Tamsulosin Hcl Generic | 414 | 1,154 | 158 | $4,840 |
Brand drugs: 2,516 claims; generic drugs: 20,831 claims; opioid claims: 571.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alejandro Rocha Jr. $1,610 ($1,610 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $409.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $409 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $266 |
| Novo Nordisk Inc NVO | 4 | $194 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $122 |
| Merck Sharp & Dohme LLC MRK | 5 | $107 |
| Pfizer Inc. PFE | 4 | $73.94 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $70.62 |
| Lilly USA, LLC LLY | 4 | $62.27 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $58.24 |
| GlaxoSmithKline, LLC. GSK | 3 | $57.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.